RSS-developed cancer drug gets US patent
Last Updated: Thursday, June 17, 2010, 00:00
  

Nagpur: An anti-cancer drug extracted from cow urine and developed by an affiliate of the RSS has got a US patent for the third time for its anti-genotoxicity properties, a senior official has said.



The drug developed by RSS-backed Go Vigyan Anusandhan Kendra had earlier got the US patent as a bio-enhancer with antibiotics and anti-cancer drugs.

The research for the drug brand named `Kamdhenu Ark` was carried out jointly by the Anusandhan Kendra and National Environmental Engineer Research Institute (NEERI), Acting Director of NEERI Tapan Chakraborty said.



The research found that Re-distilled Cow Urine Distillate (RCUD) was useful for protecting and repairing DNA from oxidative damage, Chakraborty and Sunil Mansinghka of Kendra told reporters yesterday.



Oxidative DNA damage is a leading cause of ageing, cancer and other diseases.



RCUD works against genotoxicity, a harmful action on a cell`s genetic material, they said, adding research has strengthened the efficacy of `Kamdhenu Ark` as an anti-cancer drug.

The research was carried out on three patients, two of them having throat and uterus cancer, Mansinghka said.



PTI


First Published: Thursday, June 17, 2010, 00:00



comments powered by Disqus